538964 — MERCURY LABORATORIES Share Price
0.000.00%
Last trade - 00:00- IN₹1.23bn
- IN₹1.21bn
- IN₹755.59m
- 72
- 27
- 51
- 48
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | n/a | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 2.09 | ||
| Price to Tang. Book | 2.09 | ||
| Price to Free Cashflow | 54.37 | ||
| Price to Sales | 1.41 | ||
| EV to EBITDA | 11.44 | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | 11.3% | ||
| Return on Equity | 11.72% | ||
| Operating Margin | 8.23% | ||
Financial Summary
| Year End 31st Mar | Unit | 2020 | 2021 | 2022 | 2023 | 2024 | 2025E | 2026E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | IN₹m | 572.69 | 686.01 | 579.24 | 753.34 | 755.59 | n/a | n/a | 6.36% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | +16.1 | +60.97 | -42.2 | +56.62 | +1.36 | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Mercury Laboratories Limited is an India-based pharmaceutical company. The Company operates through the Pharmaceuticals Products segment. The Company is engaged in the manufacturing and export of a range of pharmaceutical items. The products of the Company are in the segment of gynecology and pediatrics. Its products include antibiotic, antifungal, and antiviral formulations; anti-inflammatory formulations; antimalarial formulations; digestive formulations; hypoglycemic formulations; multivitamin formulations; central nervous system formulations; gynec formulations; CVS formulations; cough and cold formulations; and miscellaneous formulations, among others. Its antibiotic, antifungal, and antiviral formulations include azithromycin tablets, azithromycin dispersible tablets, griseofulvin tablets, metronidazole tablets, and others. Its anti-inflammatory formulations include dexamethasone tablets, glucosamine sulphate tablets, dexamethasone sodium phosphate injection, and others.
Directors
- Divyakant Zaveri NEC
- Enu Khandelwal CFO
- Kinjal Khandelwal CCO
- Rajendra Shah MDR
- Paresh Mistry NED (52)
- Dilip Shah NED
- Janki Shah NED
- Bharat Mehta NID
- Last Annual
- March 31st, 2024
- Last Interim
- March 31st, 2024
- Incorporated
- February 12th, 1982
- Public Since
- February 23rd, 2015
- No. of Employees
- 469
- Sector
- Pharmaceuticals
- Industry
- Healthcare
- Exchange
- Bombay Stock Exchange
- Shares in Issue
- 1,200,000
- Address
- 2/13 & 2/14, VADODARA, 390016
- Web
- http://www.mercurylabs.com/
- Phone
- +91 2652280180
- Auditors
- Naresh & Co.
Upcoming Events for 538964
Mercury Laboratories Ltd Annual Shareholders Meeting
Q2 2025 Mercury Laboratories Ltd Earnings Release
Similar to 538964
Achyut Healthcare
Bombay Stock Exchange
Adline Chem Lab
Bombay Stock Exchange
MPS Pharmaa
Bombay Stock Exchange
Albert David
Bombay Stock Exchange
Ambalal Sarabhai Enterprises
Bombay Stock Exchange
FAQ
What is the MERCURY LABORATORIES share price?
As of Today at 16:03 UTC, shares in MERCURY LABORATORIES are trading at IN₹885.00. This share price information is delayed by 15 minutes.
How has the MERCURY LABORATORIES share price performed this year?
Shares in MERCURY LABORATORIES last closed at IN₹885.00 and the price had moved by +7.8% over the past 365 days. In terms of relative price strength the MERCURY LABORATORIES share price has underperformed the S&P BSE 100 Index by -17.63% over the past year.
What are the analyst and broker recommendations for MERCURY LABORATORIES?
There is no consensus recommendation for this security.
What is the MERCURY LABORATORIES dividend yield?
The MERCURY LABORATORIES dividend yield is 0.4% based on the trailing twelve month period.
Does MERCURY LABORATORIES pay a dividend?
Last year, MERCURY LABORATORIES paid a total dividend of IN₹3.50, and it currently has a trailing dividend yield of 0.4%. We do not have any data on when MERCURY LABORATORIES is to next pay dividends.
When does MERCURY LABORATORIES next pay dividends?
We do not have data on when MERCURY LABORATORIES is to next pay dividends. The historic dividend yield on MERCURY LABORATORIES shares is currently 0.4%.
How do I buy MERCURY LABORATORIES shares?
To buy shares in MERCURY LABORATORIES you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
What is the market cap of MERCURY LABORATORIES?
As of the previous close price of IN₹885.00, shares in MERCURY LABORATORIES had a market capitalisation of IN₹1.06bn.
Where are MERCURY LABORATORIES shares listed?
Here are the trading details for MERCURY LABORATORIES:
- Country of listing: India
- Exchange: BSE
- Ticker Symbol: 538964
What kind of share is MERCURY LABORATORIES?
Based on an overall assessment of its quality, value and momentum MERCURY LABORATORIES is currently classified as a Falling Star. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
Is there a MERCURY LABORATORIES share price forecast for 2024?
We could not find analyst target price data for this security.
What is the trend in the MERCURY LABORATORIES share price?
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like MERCURY LABORATORIES. Over the past six months, its share price has underperformed the S&P BSE 100 Index by -21.83%.
As of the last closing price of IN₹885.00, shares in MERCURY LABORATORIES were trading -0.55% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
What is the MERCURY LABORATORIES PE Ratio?
The MERCURY LABORATORIES PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at IN₹885.00.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Who are the key directors of MERCURY LABORATORIES?
MERCURY LABORATORIES' management team is headed by:
- Divyakant Zaveri - NEC
- Enu Khandelwal - CFO
- Kinjal Khandelwal - CCO
- Rajendra Shah - MDR
- Paresh Mistry - NED
- Dilip Shah - NED
- Janki Shah - NED
- Bharat Mehta - NID